NCT03514017 2026-03-02Ibrutinib and PD-1 Blockade in High Risk Lymphocytic LeukemiaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated5 enrolled 11 charts
NCT01998828 2020-04-20Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaSierra Oncology LLC - a GSK companyPhase 2 Terminated39 enrolled